IN2012MU00206A - - Google Patents

Download PDF

Info

Publication number
IN2012MU00206A
IN2012MU00206A IN206MU2012A IN2012MU00206A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A IN 206MU2012 A IN206MU2012 A IN 206MU2012A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A
Authority
IN
India
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN206MU2012 priority Critical patent/IN2012MU00206A/en
Priority to US13/745,010 priority patent/US9283270B2/en
Publication of IN2012MU00206A publication Critical patent/IN2012MU00206A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IN206MU2012 2012-01-20 2012-01-20 IN2012MU00206A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (fr) 2012-01-20 2012-01-20
US13/745,010 US9283270B2 (en) 2012-01-20 2013-01-18 Method for stabilization of biological molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (fr) 2012-01-20 2012-01-20

Publications (1)

Publication Number Publication Date
IN2012MU00206A true IN2012MU00206A (fr) 2013-08-09

Family

ID=48945734

Family Applications (1)

Application Number Title Priority Date Filing Date
IN206MU2012 IN2012MU00206A (fr) 2012-01-20 2012-01-20

Country Status (2)

Country Link
US (1) US9283270B2 (fr)
IN (1) IN2012MU00206A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2627156C2 (ru) 2012-11-21 2017-08-03 Серум Инститьют Оф Индия Прайват Лтд. Высокоэффективный способ получения бактериального полисахарида, получение конъюгата на его основе и иммуногенная композиция
EP3283102A4 (fr) 2015-04-16 2018-10-03 Inventprise, LLC. Compositions de vaccin immunogène à base de bordetella pertussis
WO2016200787A2 (fr) 2015-06-09 2016-12-15 The Board Of Regents Of The University Of Oklahoma Compositions et traitements pour haemophilus influenzae
EP3344276B1 (fr) 2015-09-03 2020-04-22 The Board of Regents of the University of Oklahoma Inhibiteurs peptidiques de toxine tcdb declostridium difficile
KR102906912B1 (ko) 2016-09-02 2026-01-05 사노피 파스퇴르 인크 네이세리아 메닌기티디스 백신
US11400162B2 (en) * 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
AU2018328040B2 (en) 2017-09-07 2025-01-16 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
CN107828360A (zh) * 2017-11-16 2018-03-23 西安长峰机电研究所 一种常温固化固体火箭发动机喷管结构粘接剂
EP3781192A1 (fr) 2018-04-16 2021-02-24 Merck Patent GmbH Additifs pour formulations protéiques en vue d'améliorer la stabilité thermique
JOP20200214A1 (ar) * 2019-09-03 2021-03-03 Serum Institute Of India Pvt Ltd تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها
NL2023863B1 (en) * 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof
WO2022035816A1 (fr) 2020-08-10 2022-02-17 Inventprise, Llc Vaccins glycoconjugués pneumococciques multivalents contenant un sérotype 24f émergent
WO2024233456A1 (fr) 2023-05-05 2024-11-14 The Board Of Regents Of The University Of Oklahoma Variants d'adrénomédulline (am) et d'adrénomédulline 2/intermédine (am2/imd) et procédés d'utilisation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2065023A1 (fr) 1989-08-15 1991-02-16 Brent Dorval Vaccin compose d'elements stabilises
CA2177060A1 (fr) 1993-12-21 1995-06-29 Philip J. Provost Herpesvirus varicellae thermostable
JP2000507963A (ja) 1996-12-20 2000-06-27 メルク エンド カンパニー インコーポレーテッド 凍結乾燥ワクチン用安定剤
CN1053590C (zh) 1998-10-19 2000-06-21 卫生部长春生物制品研究所 冻干甲型肝炎减毒活疫苗及其保护剂
PT1233784E (pt) 1999-12-02 2008-11-03 Novartis Vaccines & Diagnostic Composições e métodos para a estabilização de moléculas biológicas após a liofilização
CA2688268A1 (fr) * 2007-06-04 2008-12-11 Novartis Ag Formulation de vaccins contre la meningite
WO2009050586A1 (fr) * 2007-10-19 2009-04-23 Novartis Ag Formulations de vaccin méningococcique
BRPI0800357A2 (pt) 2008-03-10 2009-10-27 Fundacao Oswaldo Cruz método para produção de uma vacina estabilizada
CN102802662A (zh) * 2010-03-18 2012-11-28 诺华有限公司 用于脑膜炎球菌血清组b的含佐剂疫苗

Also Published As

Publication number Publication date
US9283270B2 (en) 2016-03-15
US20130209503A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
BR122020002986A2 (fr)
BR112014017635A2 (fr)
BR112014020069A2 (fr)
BR112014017659A2 (fr)
BR112014017607A2 (fr)
BR112014017646A2 (fr)
BR112014023589A2 (fr)
BR112014017638A2 (fr)
AR092201A1 (fr)
BR112013027865A2 (fr)
BR112014017644A2 (fr)
BR112014019239A2 (fr)
BR112014017634A2 (fr)
BR112014017647A2 (fr)
BR112014017588A2 (fr)
BR112014013184A8 (fr)
BR112014017627A2 (fr)
BR112014017652A2 (fr)
BR112014017630A2 (fr)
IN2012MU00206A (fr)
BR112014017631A2 (fr)
BR112014017641A2 (fr)
BR112014018670A2 (fr)
BR112014023585A2 (fr)
BR112014018028A2 (fr)